Insulin-like growth factor system in patients with HIV infection: Effect of exogenous growth hormone administration

Citation
Dc. Mynarcik et al., Insulin-like growth factor system in patients with HIV infection: Effect of exogenous growth hormone administration, J ACQ IMM D, 22(1), 1999, pp. 49-55
Citations number
32
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
ISSN journal
15254135 → ACNP
Volume
22
Issue
1
Year of publication
1999
Pages
49 - 55
Database
ISI
SICI code
1525-4135(19990901)22:1<49:IGFSIP>2.0.ZU;2-S
Abstract
The purpose of this study was to characterize changes in the levels of insu lin-like growth factor-I (IGF-I) and IGF binding proteins (BP) 1, 2, and 3 in HIV-infected adults throughout the course of their disease, and to asses s the responsiveness of the IGF system components to growth hormone (GH) ad ministration (6 mg/day) for 2 weeks. Healthy control study subjects (n = 10 ) were compared with patients who were either HIV-positive (n = 9), had AID S without weight loss (n = 13), or had AIDS with >10% weight loss (n = 6), all of whom had been free of acute illness for at least 3 months. Under bas al conditions, fasting serum concentrations of epinephrine, norepinephrine, cortisol, glucagon, insulin, IGF-I, and IGFBP-3 were not significantly dif ferent among the four groups. The serum concentrations of IGFBP-1 and IGFBP -2 were significantly higher in AIDS patients with wasting than in the othe r three groups (p < .05). In addition, there was a statistically significan t positive correlation between the levels of IGFBP-1 (p = .004) and IGFBP-2 (p = .03) and the stage of disease. Following GH administration, the serum concentrations of insulin and IGF-I were increased in all groups (p < .05) . In addition, the increases in insulin levels correlated with stage of dis ease (p = .004). The responses of the IGFBPs were more variable. GH adminis tration significantly increased the levels of IGFBP-3 in all groups except the patients with AIDS wasting, whereas the levels of IGFBP-1 were signific antly decreased in controls and AIDS patients. These results demonstrate th at there is a continuum of both elevations in the IGFBPs and altered metabo lic responsiveness in patients infected with HIV that increases with the se verity of the disease. These data also demonstrate that AIDS patients, who are free from secondary infection, respond to administration of GH by signi ficantly increasing hepatic IGF-I production.